FDA releases its latest batch of Warning Letters that includes Huron Pharmaceuticals, Lonza Group, Rainbow Gold Products, and Vikshara Trading & Inves...
CDERs Sau Lee says FDA is taking steps to facility drug manufacturer use of emerging technologies such as continuous manufacturing.
The Senate Health, Education, Labor, and Pensions Committee releases a Managers Amendment to S. 934 FDA Reauthorization Act of 2017 that would reautho...
Reuters says the Justice Department is looking into allegations involving several Johnson & Johnson drugs.
FDA chief information officer Todd Simpson describes the agencys move to a data management platform that can incorporate cloud storage,
A new study published in JAMA finds that nearly a third of recently approved drugs resulted in adverse events that led to new boxed warnings or safety...
C.O. Truxton expands an ongoing recall to now include all phenobarbital and amitriptyline tablets that were repackaged into a Truxton label due to the...
The Project on Government Oversight says HHS is attempting to restrict its employees from communicating to Congress as whistleblowers reporting wrongd...